Intravitreal Avastin for macular oedema secondary to retinal vein occlusion: a prospective study.

@article{Kriechbaum2008IntravitrealAF,
  title={Intravitreal Avastin for macular oedema secondary to retinal vein occlusion: a prospective study.},
  author={Karmon Kriechbaum and Stephan Michels and Franz Prager and Michael Georgopoulos and Marion Funk and Wolfgang Geitzenauer and Ursula M Schmidt-Erfurth},
  journal={The British journal of ophthalmology},
  year={2008},
  volume={92 4},
  pages={518-22}
}
OBJECTIVE To evaluate efficacy and safety of intravitreal bevacizumab (Avastin) in eyes with macular oedema secondary to central retinal vein occlusion (CRVO) or branch retinal vein occlusion (BRVO). METHODS Twenty-eight consecutive patients (28 patients, 29 eyes, 8 CRVO, 21 BRVO) were enrolled in the study. Three intravitreal injections of 1 mg bevacizumab (0.04 ml) were administered at 4-week intervals; further retreatment was based on optical coherence tomography (OCT) findings. Follow-up… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 82 extracted citations

Similar Papers

Loading similar papers…